Detalhe da pesquisa
1.
Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210).
Cytotherapy
; 26(1): 25-35, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37897472
2.
Donor selection for adoptive cell therapy with CD45RA- memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype, proliferation and interferon gamma release.
Cytotherapy
; 25(3): 330-340, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36585293
3.
Identifying SARS-CoV-2 'memory' NK cells from COVID-19 convalescent donors for adoptive cell therapy.
Immunology
; 165(2): 234-249, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775592
4.
Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma.
Blood
; 135(26): 2375-2387, 2020 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32299093
5.
Failure of Viral-Specific T Cells Administered in Pre-transplant Settings in Children with Inborn Errors of Immunity.
J Clin Immunol
; 41(4): 748-755, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33462728
6.
The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus-6B encephalitis after naïve T-cell-depleted allogeneic stem cell transplantation.
Transfusion
; 61(5): 1505-1517, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33713461
7.
Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients.
Ann Hematol
; 100(8): 1995-2004, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33409621
8.
Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients.
Pharmacogenomics J
; 20(5): 664-671, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32015457
9.
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study.
Ann Intern Med
; 168(7): 461-470, 2018 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29459949
10.
Unexpected High Incidence of Human Herpesvirus-6 Encephalitis after Naive T Cell-Depleted Graft of Haploidentical Stem Cell Transplantation in Pediatric Patients.
Biol Blood Marrow Transplant
; 24(11): 2316-2323, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30031939
11.
How do we manufacture clinical-grade interleukin-15-stimulated natural killer cell products for cancer treatment?
Transfusion
; 58(6): 1340-1347, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29542132
12.
Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group.
Am J Hematol
; 92(9): E534-E541, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28612357
13.
Excess mortality in the myelodysplastic syndromes.
Am J Hematol
; 92(2): 149-154, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27859564
14.
Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications.
Ann Hematol
; 94(5): 779-87, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25516455
15.
Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion.
Br J Haematol
; 166(2): 189-201, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24716538
16.
High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma.
Blood
; 119(3): 687-91, 2012 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22128143
17.
A phase 2, randomized, double-blind, multicenter study comparing siltuximab plus best supportive care (BSC) with placebo plus BSC in anemic patients with International Prognostic Scoring System low- or intermediate-1-risk myelodysplastic syndrome.
Am J Hematol
; 89(9): E156-62, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24888488
18.
Do chronic myeloid leukemia patients with late "warning" responses benefit from "watch and wait" or switching therapy to a second generation tyrosine kinase inhibitor?
Am J Hematol
; 89(11): E206-11, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25059397
19.
Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing.
Genes Chromosomes Cancer
; 52(12): 1167-77, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24123380
20.
Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation.
Biol Blood Marrow Transplant
; 19(9): 1387-92, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23850652